Are you Xisheng Yan?

Claim your profile

Publications (2)8.78 Total impact

  • Article: Endogenous activation of presynaptic NMDA receptors enhances glutamate release from the primary afferents in the spinal dorsal horn in a rat model of neuropathic pain.
    [show abstract] [hide abstract]
    ABSTRACT: Activation of N-Methyl-D-aspartate (NMDA) receptors is a crucial mechanism underlying the development and maintenance of pain. Traditionally, the role of NMDA receptors in the pathogenesis of pain is ascribed to their activation and signaling cascades in postsynaptic neurons. In this study, we determined if presynaptic NMDA receptors in the primary afferent central terminals play a role in synaptic plasticity of the spinal first sensory synapse in a rat model of neuropathic pain induced by spinal nerve ligation. Excitatory postsynaptic currents (EPSCs) were recorded from superficial dorsal horn neurons of spinal slices taken from young adult rats. We showed that increased glutamate release from the primary afferents contributed to the enhanced amplitudes of EPSCs evoked by input from the primary afferents in neuropathic rats. Endogenous activation of presynaptic NMDA receptors increased glutamate release from the primary afferents in neuropathic rats. Presynaptic NMDA receptors in neuropathic rats were mainly composed of NR2B receptors. The action of presynaptic NMDA receptors in neuropathic rats was enhanced by exogenous D-serine and/or NMDA and dependent on activation of protein kinase C. In contrast, glutamate release from the primary afferents in sham-operated rats was not regulated by presynaptic NMDA receptors. We demonstrated that the lack of NMDA receptor-mediated regulation of glutamate release in sham-operated rats was not attributable to low extracellular levels of the NMDA receptor agonist and/or coagonist (D-serine), but rather was due to the insufficient function and/or number of presynaptic NMDA receptors. This was supported by an increase of NR2B receptor protein expression in both the dorsal root ganglion and spinal dorsal horn ipsilateral to the injury site in neuropathic rats. Hence, suppression of the presynaptic NMDA receptor activity in the primary sensory afferents is an effective approach to attenuate the enhanced glutamatergic response in the spinal first sensory synapse induced by peripheral nerve injury, and presynaptic NMDA receptors might be a novel target for the development of analgesics.
    The Journal of Physiology 01/2013; · 4.72 Impact Factor
  • Article: Glial glutamate transporter and glutamine synthetase regulate GABAergic synaptic strength in the spinal dorsal horn.
    Enshe Jiang, Xisheng Yan, Han-Rong Weng
    [show abstract] [hide abstract]
    ABSTRACT: Decreased GABAergic synaptic strength ('disinhibition') in the spinal dorsal horn is a crucial mechanism contributing to the development and maintenance of pathological pain. However, mechanisms leading to disinhibition in the spinal dorsal horn remain elusive. We investigated the role of glial glutamate transporters (GLT-1 and GLAST) and glutamine synthetase in maintaining GABAergic synaptic activity in the spinal dorsal horn. Electrically evoked GABAergic inhibitory post-synaptic currents (eIPSCs), spontaneous IPSCs (sIPSCs) and miniature IPSCs were recorded in superficial spinal dorsal horn neurons of spinal slices from young adult rats. We used (2S,3S)-3-[3-[4-(trifluoromethyl)benzoylamino]benzyloxy]aspartate (TFB-TBOA), to block both GLT-1 and GLAST and dihydrokainic acid to block only GLT-1. We found that blockade of both GLAST and GLT-1 and blockade of only GLT-1 in the spinal dorsal horn decreased the amplitude of GABAergic eIPSCs, as well as both the amplitude and frequency of GABAergic sIPSCs or miniature IPSCs. Pharmacological inhibition of glial glutamine synthetase had similar effects on both GABAergic eIPSCs and sIPSCs. We provided evidence demonstrating that the reduction in GABAergic strength induced by the inhibition of glial glutamate transporters is due to insufficient GABA synthesis through the glutamate-glutamine cycle between astrocytes and neurons. Thus, our results indicate that deficient glial glutamate transporters and glutamine synthetase significantly attenuate GABAergic synaptic strength in the spinal dorsal horn, which may be a crucial synaptic mechanism underlying glial-neuronal interactions caused by dysfunctional astrocytes in pathological pain conditions.
    Journal of Neurochemistry 02/2012; 121(4):526-36. · 4.06 Impact Factor